Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent.
A new layered organic-inorganic nanocomposite material with an anti-parkinsonian active compound, L-3-(3,4-dihydroxyphenyl) alanine (levodopa), intercalated into the inorganic interlayers of a Zn/Al-layered double hydroxide (LDH) was synthesized using a direct coprecipitation method. The resulting n...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English English |
| Published: |
Dove Medical Press
2013
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/29991/1/Development%20of%20a%20controlled.pdf |